StonvexLoading…
StonvexStonvexStonvexCore line items from THR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Annual 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $118.32M | $536.26M | $387.93M | $240.62M | $108.90M |
Operating Income | Not available | $70.74M | $59.96M | $33.31M | $11.73M |
Net Income | Not available | $44.57M | $41.83M | $14.95M | $8.58M |
EPS (Diluted) | $0.39 | $1.36 | $1.27 | $0.71 | $0.26 |
Total Assets | Not available | $830.58M | $816.70M | $778.18M | $765.34M |
Total Liabilities | Not available | $291.87M | $278.00M | $262.95M | $256.03M |
Cash & Equivalents | Not available | $52.27M | $46.86M | $29.75M | $36.53M |
Free Cash Flow OCF − CapEx | Not available | $32.86M | $25.75M | $12.68M | $8.32M |
Shares Outstanding | Not available | 32.87M | 32.85M | 32.84M | 33.06M |